Plain-English translation of NCT03041701 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Lung cancer research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
United States
Phase
Safety & dosing / Early efficacy
Sponsor
National Cancer Institute (NCI)
Enrollment target
~14 participants
Started
July 2017
Primary completion
September 2021
Age range
2 Years and older
Last updated on clinicaltrials.gov in April 2022.